- Home
- AZIO vs DYAI Comparison
AZIO vs DYAI Comparison
Compare AZIO & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AZIO | DYAI |
|---|---|---|
| Founded | 2021 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.4M | 17.0M |
| IPO Year | 2014 | 2026 |
Fundamental Metrics
Financial Performance| Metric | AZIO | DYAI |
|---|---|---|
| Price | $1.01 | $0.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 271.9K | 131.5K |
| Earning Date | 11-20-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,939,008.00 | $3,090,345.00 |
| Revenue This Year | N/A | $113.16 |
| Revenue Next Year | N/A | $94.92 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 217.58 | N/A |
| 52 Week Low | $0.83 | $0.34 |
| 52 Week High | $1.84 | $1.60 |
Technical Indicators
Market Signals| Indicator | AZIO | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 39.18 | 33.95 |
| Support Level | N/A | $0.34 |
| Resistance Level | $1.45 | $0.50 |
| Average True Range (ATR) | 0.11 | 0.04 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 40.76 | 12.36 |
Price Performance
Historical ComparisonAbout AZIO Azio AI Holdings Inc. Common Stock
Azio AI Holdings Inc is a technology infrastructure company focused on developing, owning, and operating artificial intelligence data centers, enterprise GPU compute infrastructure, digital power solutions, and digital asset mining operations. The company operates an integrated AI infrastructure business encompassing AI data center development, the sale and distribution of enterprise GPU systems and server infrastructure, high-performance computing solutions, power hosting, and strategic technology investments, serving enterprise and institutional customers across domestic and international markets.
About DYAI Dyadic International Inc.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.